Status:
UNKNOWN
Hepatitis B Prevalence in the Turkish Population Living in Middle Limburg
Lead Sponsor:
Hasselt University
Conditions:
Hepatitis B
Eligibility:
All Genders
18+ years
Brief Summary
This study will assess HBV (HBsAg, anti-HBc and anti-HBs) prevalence in the Turkish population living in Belgium. Additionally, the investigators will determine the risk factors for HBV infection and ...
Detailed Description
HBV infection is an important public health problem in the Turkish population, i.e. one of the largest migrant populations in Europe. With the introduction of cost-effective antiviral treatments in th...
Eligibility Criteria
Inclusion
- Turkish origin, defined as one of the parents born in Turkey
- Having a signed informed consent form
Exclusion
- /
Key Trial Info
Start Date :
September 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2020
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03396458
Start Date
September 1 2017
End Date
August 31 2020
Last Update
January 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ziekenhuis Oost-Limburg
Genk, Limburg, Belgium, 3600